SEARCH

SEARCH BY CITATION

References

  • https://ocm.ama-assn.org, CodeManager (Metropolitan Boston).
  • (2008). The Red Book of Medicines, Thomson Health Care: Newark.
  • Alons K, Kuijpers SC, deJong E, vanMerkesteyn JP (2009). Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107: e1e7.
  • Bagan JV, Jimenez Y, Murillo J et al (2006). Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 42: 327329.
  • Bamias A, Kastritis E, Bamia C et al (2005). Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23: 85808587.
  • Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R (2006). Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35: 236243.
  • Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA (2008). Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 139: 16741677.
  • Khan AA, Sandor GK, Dore E et al (2008). Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35: 13911397.
  • Lam DK, Sandor GK, Holmes HI, Evans AW, Clokie CM (2007). A review of bisphosphonate-associated osteonecrosis of the jaws and its management. J Can Dent Assoc 73: 417422.
  • Lo JC, O'Ryan FS, Gordon NP et al (2009). Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68: 243253.
  • Marx RE, Sawatari Y, Fortin M, Broumand V (2005). Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 15671575.
  • Migliorati CA, Siegel MA, Elting LS (2006). Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7: 508514.
  • Miksad RA, Lai KC, Dodson TB et al (2011). Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16: 121132.
  • Ruggiero SL, Woo SB (2008). Bisphosphonate-related osteonecrosis of the jaws. Dent Clin North Am 52: 111128.
  • Ruggiero S, Gralow J, Marx RE et al (2006). Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2: 714.
  • Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009). American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws–2009 update. J Oral Maxillofac Surg 67: 212.
  • Thumbigere-Math V, Sabino MC, Gopalakrishnan R et al (2009). Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 67: 19041913.
  • Treister N, Sheehy N, Bae EH, Friedland B, Lerman M, Woo S (2009). Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws. Oral Dis 15: 8892.
  • Tubiana-Hulin M, Spielmann M, Roux C et al (2009). Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis. Crit Rev Oncol Hematol 71: 1221.
  • Weitzman R, Sauter N, Eriksen EF et al (2007). Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients–May 2006. Crit Rev Oncol Hematol 62: 148152.
  • Williamson RA (2010). Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 39: 251255.
  • Wongchuensoontorn C, Liebehenschel N, Wagner K et al (2009). Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases. J Oral Maxillofac Surg 67: 13111316.